Literature DB >> 12360436

Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: a matched, case-controlled study.

Elizabeth W Jackson1, Steven Zacks, Sandra Zinn, John Ryan, Mark W Johnson, David A Gerber, Kenneth Andreoni, Jeffrey H Fair, Roshan Shrestha, Michael W Fried.   

Abstract

Although several studies have identified posttransplant neurologic sequelae in patients with acute liver failure (ALF), the effects of these sequelae on neuropsychologic functioning after transplant is unknown. This study compared neuropsychologic functioning of ALF patients with chronic liver disease patients after liver transplantation. After liver transplantation, seven ALF patients were compared with a matched control group of patients who had been transplanted for chronic liver disease. The patients were matched by gender, age (within 5 years), and time since transplantation (within 2 years). Patients completed a 2-hour battery of tests, which included measures of attention, memory, motor performance, abstract conceptualization, and visuospatial perception. There were no significant differences between the groups on measures of socioeconomic status or education. Significant differences were found on three separate tests: WAIS-III Vocabulary, WAIS-III Similarities, and WMS-III Paired Associate Learning II. Although these tests measure distinct functions (vocabulary knowledge, abstract conceptualization, and delayed verbal recall), they may be influenced by broader verbal functions, such as verbal fluency, conceptualization, and the ability to articulate ideas. When patients were asked what functions had noticeably deteriorated since transplantation, nearly all complained of memory difficulties, and there was no difference between groups. However, more ALF than chronic liver disease (CLD) patients complained of concentration difficulties. The results of this study suggest that ALF patients may experience more neuropsychologic dysfunction after transplant. Further studies are required to expand on these initial observations with the potential to improve patient care and referral to appropriate rehabilitative services.

Entities:  

Mesh:

Year:  2002        PMID: 12360436     DOI: 10.1053/jlts.2002.35550

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

1.  Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis.

Authors:  Ryan M Taylor; Shannan Tujios; Kartik Jinjuvadia; Timothy Davern; Obaid S Shaikh; Steve Han; Raymond T Chung; William M Lee; Robert J Fontana
Journal:  Dig Dis Sci       Date:  2011-09-27       Impact factor: 3.199

2.  Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study.

Authors:  Robert J Fontana; Caitlyn Ellerbe; Valerie E Durkalski; Amol Rangnekar; Rajender K Reddy; Todd Stravitz; Brendan McGuire; Timothy Davern; Adrian Reuben; Iris Liou; Oren Fix; Daniel R Ganger; Raymond T Chung; Mike Schilsky; Steven Han; Linda S Hynan; Corron Sanders; William M Lee
Journal:  Liver Int       Date:  2014-07-28       Impact factor: 5.828

Review 3.  Management of acute liver failure.

Authors:  R Todd Stravitz; David J Kramer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-04       Impact factor: 46.802

4.  Acute liver failure: Summary of a workshop.

Authors:  William M Lee; Robert H Squires; Scott L Nyberg; Edward Doo; Jay H Hoofnagle
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

5.  Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients.

Authors:  Amol S Rangnekar; Caitlyn Ellerbe; Valerie Durkalski; Brendan McGuire; William M Lee; Robert J Fontana
Journal:  Liver Transpl       Date:  2013-08-18       Impact factor: 5.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.